Status:
ACTIVE_NOT_RECRUITING
A Clinical Trial to Examine the Efficacy of a Supplement to Support Healthy Hair and Skin
Lead Sponsor:
Scale Media Inc
Collaborating Sponsors:
Citruslabs
Conditions:
Hair Thinning
Hair Loss
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
This is a triple-blinded, randomized, placebo-controlled clinical trial designed to evaluate the efficacy of Scale Media's Live Conscious Beyond Collagen supplement on overall hair and skin health. Th...
Eligibility Criteria
Inclusion
- Female or male
- Self-perceived hair thinning, specifically on the top and crown of the scalp for at least three months
- Self-perceived increased hair shedding for at least three months
- Concerns regarding skin health and appearance
- Has been using the same hair care routine and products for at least one month prior to the study, i.e., shampoo, conditioner, and products
- Has been using the same skincare routine and products for at least one month prior to the study, i.e., moisturizer, serums, etc.
- Willing to maintain the same hair care routine and products throughout the study
- Willing to maintain the same skincare routine and products throughout the study
- Willing to maintain the same diet and exercise regimen during the study
- Willing to refrain from taking any vitamins, minerals, or herbal supplements that target hair growth or skin health during the study
- Willing to refrain from taking any new vitamins, minerals, or supplements of any kind during the study
- Willing to avoid introducing any new prescription medications or supplements that target hair health and appearance of skin health and appearance during the study
- Be generally healthy and do not live with any uncontrolled chronic disease
- Willing to stop taking any other multivitamin supplements at least one month prior to and for the entire study duration
- Willing to avoid dyeing the hair for the duration of the study
- Living with someone who can take their study photos for the duration of the study
Exclusion
- Anyone with a diagnosed hair loss or hair thinning health condition, except for female pattern baldness (e.g., alopecia areata)
- Women who are pregnant, breastfeeding, or trying to conceive
- Anyone currently taking iron supplements
- Anyone unwilling or unable to follow the study protocol
- Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
- Anyone who does not consume animal products for personal or religious reasons
- Is undergoing or planning to undergo laboratory testing and/or significant medical procedures during the study duration
- A history of severe allergic reactions, including but not limited to any of the product's ingredients
- Has undergone any chemical treatments to the hair in the last three months, e.g., chemical straightening, hair extensions with chemical bonding, perms, and relaxers
- Has any planned chemical treatments for the hair during the study period, e.g., chemical straightening, hair extensions with chemical bonding, perms, and relaxers
- Has any planned cosmetic treatments to the face, including botox, dermal filler, chemical peels, etc.
- Currently undergoing hair loss treatment, including mechanical scalp stimulation, or has done so in the last three months
- Currently using other hair growth/thickening products
- Currently taking any prescription medication for hair loss, or has done so in the last three months
- Currently taking any prescription medication for skin health, or has done so in the last three months
- Has undergone any surgeries or invasive treatments in the last six months
- Has had any major illness in the last three months
- Currently taking medication that has hair loss as a known or observed side effect
- Currently undergoing or have you recently undergone chemotherapy or radiotherapy
- Anyone who has had a hair transplant within the last year
Key Trial Info
Start Date :
June 7 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06579742
Start Date
June 7 2024
End Date
December 31 2024
Last Update
August 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Citruslabs
Santa Monica, California, United States, 90404